Abpro Holdings ABPO
OTC ABPO
$0.19 -0.02 (-11.26%)
As of: Aug 21, 2026 · 3:37 PM EDT

Abpro Holdings (ABPO) Change in Accured Expenses (2022 - 2026)

Abpro Holdings' (ABPO) quarterly Change in Accured Expenses came in at -$512000.0 in Q1 2026, down 764.94% YoY from $77000.0 in Q1 2025, and down 289.63% on a QoQ basis from $270000.0 in Q4 2025.

Abpro Holdings (ABPO) Change in Accured Expenses (2022 - 2026) Analysis & Trends

Abpro Holdings (ABPO) has 5 years of Change in Accured Expenses data on file, last reported at -$512000.0 in Q1 2026.

  • Quarterly Change in Accured Expenses fell 764.94% year-over-year to -$512000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$392000.0 (down 188.09% YoY) and the FY2025 annual result came in at $197000.0, down 47.88% from the prior year.
  • Change in Accured Expenses fell to -$512000.0 in Q1 2026, from $270000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.0 million in Q4 2023 to a low of -$1.1 million in Q3 2023.
  • A 5-year average of $105198.8 and a median of $240000.0 in 2025 frame the typical range for Change in Accured Expenses.
  • Annual changes were most pronounced in 2025 — Change in Accured Expenses surged 670.0% — and 2026, when it sank 764.94%.
  • Tracing ABPO's Change in Accured Expenses over 5 years: stood at $347463.0 in 2022, then surged by 191.26% to $1.0 million in 2023, then tumbled by 117.09% to -$173000.0 in 2024, then soared by 256.07% to $270000.0 in 2025, then tumbled by 289.63% to -$512000.0 in 2026.
  • The last three Change in Accured Expenses figures came in at -$512000.0 (Q1 2026), $270000.0 (Q4 2025), and -$390000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 11.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 212.44 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 61.62 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 68.82 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Abpro Holdings 1.14 Mn 1.14 Mn - 24,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -512,000.00
Mar 31, 2026 -512,000.00
Dec 31, 2025 270,000.00
Dec 31, 2025 270,000.00
Sep 30, 2025 -390,000.00
Sep 30, 2025 -390,000.00
Jun 30, 2025 240,000.00
Jun 30, 2025 240,000.00
Mar 31, 2025 77,000.00
Mar 31, 2025 77,000.00
Dec 31, 2024 -173,000.00
Dec 31, 2024 -173,000.00
Sep 30, 2024 415,000.00
Sep 30, 2024 415,000.00
Jun 30, 2024 126,000.00
Jun 30, 2024 126,000.00
Mar 31, 2024 10,000.00
Mar 31, 2024 10,000.00
Dec 31, 2023 1.01 Mn
Dec 31, 2023 1.01 Mn